Importance of circulating tumor cells in newly diagnosed colorectal cancer

International Journal of Oncology

Volumn 46, Issue 3, 2015, Pages 1361-1368

  Van Dalum, Guus ^a   Stam, Gerrit Jan ^a   Scholten, Loes F A ^b   Mastboom, Walter J B ^b   Vermes, Istvan ^b   Tibbe, Arjan G J ^a   De Groot, Marco R ^b   Terstappen, Leon W M M ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Circulating tumor cells; Colon cancer related death; Colorectal cancer

Indexed keywords

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; VERY ELDERLY; ADOLESCENT; BLOOD; CAUSE OF DEATH; COHORT ANALYSIS; COLORECTAL TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL; TUMOR EMBOLISM; YOUNG ADULT;

TUMOR MARKER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84921924652     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.2824     Document Type: Article

References (31)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 58: 71-96, 2008.
2. Shah S, Haddad R and Al-Sukhni W: Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 202: 468-475, 2006.
3. Safi F and Beyer HG: The value of follow-up after curative surgery of colorectal carcinoma. Cancer Detect Prev 17: 417-424, 1993.
4. André T, Boni C, Navarro M, et al: Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27: 3109-3016, 2009.
5. Allard WJ, Matera J, Miller MC, et al: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004.
6. Cristofanilli M and Budd G: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. Engl J Med 351: 781-791, 2004.
7. De Bono JS, Scher HI, Montgomery RB, et al: Circulating tumor cells predict survival benefit from treatment in metastatic castrationresistant prostate cancer. Clin cancer Res 14: 6302-6309, 2008.
8. Cohen SJ, Punt CJA, Iannotti N, et al: Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26: 3213-3221, 2008.
9. Franken B, de Groot MR, Mastboom WJB, Vermes I, van der Palen J, Tibbe AGJ and Terstappen LWMM: Circulating tumor cells, disease recurrence and survival in newly diagnosed breast cancer. Breast Cancer Res 14: R133, 2012.
10. Dalum G van, Stam GJ van der, Tibbe AGJ, et al: Circulating tumor cells before and during follow-up after breast cancer surgery. Int J Oncol 46: 407-413, 2015.
11. Liu MC, Shields PG, Warren RD, et al: Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer. J Clin Oncol 27: 5153-5159, 2009.
12. Pierga JY, Hajage D, Bachelot T, et al: High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. Ann Oncol 23: 618-624, 2012.
13. Tol J, Koopman M, Miller MC, et al: Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents. Ann Oncol 21: 1006-1012, 2010.
14. Lucci A, Hall CS, Lodhi AK, et al: Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13: 688-695, 2012.
15. Bidard FC, Mathiot C, Delaloge S, et al: Single circulating tumor cell detection and overall survival in non-metastatic breast cancer. Ann Oncol 21: 729-733, 2010.
16. Martín M, Custodio S, de Las Casas MLM, et al: Circulating tumor cells following first chemotherapy cycle: an early and strong predictor of outcome in patients with metastatic breast cancer. Oncologist 18: 917-923, 2013.
17. www.oncoline.nl. Integr Kankercent Ned, 2013.
18. R Core Team: R: A Language and Environment for Statistical Computing, 2013.
19. Jueckstock JK, Rack BK, Zwingers T, Hepp PGM, Schneeweiss A, Beckmann MW, Lichtenegger W, Sommer HL, Pantel K, Tesch H, Forstbauer H, Lorenz R, Rezai M, Neugebauer JK, Andergassen U, Friese K and Janni W: Prognostic relevance of circulating tumor cells (CTC) before adjuvant chemotherapy in patients with breast cancer: results of the German SUCCESS trial. J Clin Oncol 29 (suppl): 1033, 2011.
20. Pierga JY, Bidard FC, Mathiot C, et al: Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 14: 7004-7010, 2008.
21. Coumans FA, Siesling S and Terstappen LW: Detection of cancer before distant metastasis. BMC Cancer 13: 283, 2013.
22. Cohen SJ, Punt CJ, Iannotti N, et al: Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol 20: 1223-1229, 2009.
23. Tibbe AGJ, Miller MC and Terstappen LWMM: Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71: 154-162, 2007.
24. Thorsteinsson M, Soletormos G and Jess P: Low number of detectable circulating tumor cells in non-metastatic colon cancer. Anticancer Res 31: 613-617, 2011.
25. Sastre J, Maestro ML, Puente J, et al: Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 19: 935-938, 2008.
26. Hiraiwa K, Takeuchi H, Hasegawa H, et al: Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol 15: 3092-3100, 2008.
27. Gazzaniga P, Gianni W and Raimondi C: Circulating tumor cells in high-risk nonmetastatic colorectal cancer. Tumor Biol 34: 2507-2509, 2013.
28. Coumans FA, Ligthart ST, Uhr JW and Terstappen LWMM: Challenges in the enumeration and phenotyping of CTC. Clin cancer Res 18: 5711-5718, 2012.
29. Pantel K, Denève E, Nocca D, et al: Circulating epithelial cells in patients with benign colon diseases. Clin Chem 58: 936-940, 2012.
30. Wind J, Tuynman JB, Tibbe AG, Swennenhuis JF, Richel DJ, van Berge Henegouwen MI and Bemelman WA: Circulating tumour cells during laparoscopic and open surgery for primary colonic cancer in portal and peripheral blood. Eur J Surg Oncol 35: 942-950, 2009.
31. Bednarz-Knoll N, Alix-Panabières C and Pantel K: Clinical relevance and biology of circulating tumor cells. Breast cancer Res 13: 228, 2011.